Trump signs order to accelerate Ibogaine research for veterans with PTSD
The order focuses on advancing studies of ibogaine, a Schedule I psychedelic drug, for use in treating PTSD, traumatic brain injury, depression, anxiety, suicidal ideatiation, and opiod addiction.
Original Source
Read the full article at Jpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.